search for

News Center

Borui Biopharmaceutical (Suzhou) Co., Ltd. Accepts Listing Counseling Announcement

Borui Biopharmaceutical (Suzhou) Co., Ltd. Accepts Listing Counseling Announcement

(Summary description)


Borui Medicine


Borui Bio-Pharmaceutical (Suzhou) Co., Ltd. intends to issue an initial public offering of RMB common stock and list it, and is currently receiving guidance from Minsheng Securities Co., Ltd.

According to the relevant requirements of the China Securities Regulatory Commission, in order to improve the transparency of stock issuance and listing, prevent and mitigate risks in the securities market, and protect the legitimate rights and interests of investors, the company is willing to accept the supervision of public opinion from all walks of life and the public. The relevant contact information and report telephone announcement are as follows:
Borui Biomedical (Suzhou) Co., Ltd. is sponsored by Yuan Jiandong, Zhong Weifang, Suzhou Borui Venture Capital Management Enterprise (Limited Partnership), etc., the company's residence: Suzhou Industrial Park Xinghu Street 218 Nano Technology Park C25, legal representative: Yuan Jiandong. Contact: Wang Zhengye, Tel: 0512-62620988, Fax: 0512-62551799, Email:

The China Securities Regulatory Commission's Jiangsu Regulatory Bureau reports a telephone number: 025-84575515, and the correspondence address is 19th floor, Huatai Securities Building, 90 Zhongshan East Road, Nanjing (Postal Code 210002).

Special announcement.

Borui Biomedical (Suzhou) Co., Ltd.
December 5, 2017

Previous None
Next None
Previous: None
Next: None

Back to top ▲

Borui Medicine


Building C25-28, 218 Xinghu Road, Suzhou Industrial Park, Jiangsu Province, China

Borui Medicine




Borui Medicine


Copyright: Brilliant Biomedical (Suzhou) Co., Ltd. Website: CE Dongli · Suzhou Su ICP No. 18,000,014           

Copyright: Borui Biomedical (Suzhou) Co., Ltd. 

Powered by